ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NCYT Novacyt S.a.

69.00
0.90 (1.32%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Novacyt S.a. LSE:NCYT London Ordinary Share FR0010397232 EUR1/15TH (CDI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.90 1.32% 69.00 68.00 70.00 68.60 68.00 68.00 97,341 16:35:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
In Vitro,in Vivo Diagnostics 22.49M -25.73M - N/A 0
Novacyt S.a. is listed in the In Vitro,in Vivo Diagnostics sector of the London Stock Exchange with ticker NCYT. The last closing price for Novacyt was 68.10p. Over the last year, Novacyt shares have traded in a share price range of 36.15p to 85.40p.

Novacyt currently has 70,626,248 shares in issue.

Novacyt Share Discussion Threads

Showing 59751 to 59773 of 71875 messages
Chat Pages: Latest  2395  2394  2393  2392  2391  2390  2389  2388  2387  2386  2385  2384  Older
DateSubjectAuthorDiscuss
16/6/2021
13:52
what date are results due ?
transhoneyqueens
16/6/2021
13:52
Yes really is high risk, best to close your short, could do an #aaa and suspend then return leaving tw with another hole to fill lol lol lol
mcrudden
16/6/2021
13:42
many will dump now / sell out as this is high risk gambling stock .... could drop a lot lower before any rise now... trigger stop losses at 300p ... soon n gloom lol
transhoneyqueens
16/6/2021
13:31
Who knows, I've saved a few pennies up if it does lol
mcrudden
16/6/2021
13:26
IF WE GET SOME GOOD NEWS THIS COULD rise to 550p within a year or so.
transhoneyqueens
16/6/2021
13:19
we need buyers so I can sell above 330p now lol... STRONG BUY
hotaimstocks
16/6/2021
13:17
Trying to shake out the last few PI, could go sub 3 before back to 8-9
dazzerman4
16/6/2021
13:16
been offered 329.6p to sell 8k shares
hotaimstocks
16/6/2021
13:14
Revenues will surprise.
bobdown2
16/6/2021
13:09
share price holding up well with all the selling
hotaimstocks
16/6/2021
13:07
The mms keep dropping the bid.
This is aim in its unfair mode.. nasty..

bobdown2
16/6/2021
12:53
MMS we've had some rough treatment lately.. we are now desperate for the yearly results. Last years not this years if you get my drift.
bobdown2
16/6/2021
12:36
NEW SHORT OPENED lol
jackson83
16/6/2021
12:35
great time to bank profits before its below 330p again
jackson83
16/6/2021
12:18
great time to short IMHO lol
transhoneyqueens
16/6/2021
12:17
from 1200p to 300p lol and was 14p last year.
transhoneyqueens
16/6/2021
12:16
wait for 320p now to buy in
transhoneyqueens
16/6/2021
12:13
Drop, drip PLOP...
insideryou
16/6/2021
11:52
SELL SELL SELL bank profits lads
transhoneyqueens
16/6/2021
11:42
Not long now RNS this week !!!
dazzerman4
16/6/2021
11:38
high risk as we were 14p last year ... could tank to 275p on more negative news or a third profits warning expect 200p ... the 1000p days are now over unfortunately for us.... the share price action tells you whats going on.
hotaimstocks
16/6/2021
11:32
got a buy order in at 330p so hope it get filled later today
jackson83
16/6/2021
11:25
The company announced it had just launched two new Covid-19 testing kits – one of which has piqued my interest and may be able to propel the NCYT share price once again. The first is a three-gene assay test that allows the business to expand its reach into the travel market since it can be used to quickly verify fit-to-fly certificates. The second is more complex. It is the first single testing kit brought to market that can identify the Indian, South African, and Brazilian variants of Covid-19.

In 2020, Novacyt proved the power of being first, especially when it comes to products in exceptionally high demand. These latest product launches might be sufficient to recover the lost DHSC revenue by expanding its existing pool of private clients, and may even lead to new public sector supply contracts.

The progress made this year by the management team is encouraging. At least, I think so. And if these latest products prove to be as lucrative as the business hopes, the NCYT share price could be on the verge of making an explosive comeback

uk2day
Chat Pages: Latest  2395  2394  2393  2392  2391  2390  2389  2388  2387  2386  2385  2384  Older

Your Recent History

Delayed Upgrade Clock